Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Among Healthcare Providers Prior to the Vaccine Era in an Integrated Midwestern Healthcare System

Overview

Journal Antimicrob Steward Healthc Epidemiol

Publisher Cambridge University Press

Specialty Infectious Diseases

Date 2022 Oct 31

PMID 36310795

Authors

Elie A Saade

Xiaochun Zhang

Jaime H Noguez

Lisa M Stempak

Daniel Tisch

Christine Schmotzer

Robert A Salata

Affiliations

Soon will be listed here.

Abstract

We performed severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antinucleocapsid IgG testing on 5,557 healthcare providers and found a seroprevalence of 3.9%. African Americans were more likely to test positive than Whites, and HCWs with household exposure and those working on COVID-19 cohorting units were more likely to test positive than their peers.

Citing Articles

Diversified humoral immunity and impacts of booster vaccines: SARS-CoV-2 antibody profile and Omicron BA.2 neutralization before and after first or second boosters.

Zhang X, Windau A, Meyers J, Yang X, Dong F Microbiol Spectr. 2024; 12(10):e0060524.

PMID: 39162540 PMC: 11448022. DOI: 10.1128/spectrum.00605-24.

Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare personnel in the Midwestern United States, September 2020-April 2021.

Bosserman R, Farnsworth C, ONeil C, Cass C, Park D, Ballman C Antimicrob Steward Healthc Epidemiol. 2023; 3(1):e133.

PMID: 37592963 PMC: 10428156. DOI: 10.1017/ash.2022.375.

References

Forrest C, Xu H, Thomas L, Webb L, Cohen L, Carey T . Impact of the Early Phase of the COVID-19 Pandemic on US Healthcare Workers: Results from the HERO Registry. J Gen Intern Med. 2021; 36(5):1319-1326. PMC: 7946335. DOI: 10.1007/s11606-020-06529-z. View

Zhang X, Saade E, Noguez J, Schmotzer C . SARS-CoV-2 Seroprevalence Among First Responders in Northeastern Ohio, 2020. Public Health Rep. 2022; 138(1):140-148. PMC: 9692179. DOI: 10.1177/00333549221119143. View

Sami S, Akinbami L, Petersen L, Crawley A, Lukacs S, Weiss D . Prevalence of SARS-CoV-2 Antibodies in First Responders and Public Safety Personnel, New York City, New York, USA, May-July 2020. Emerg Infect Dis. 2021; 27(3):796-804. PMC: 7920688. DOI: 10.3201/eid2703.204340. View

Harris P, Taylor R, Minor B, Elliott V, Fernandez M, ONeal L . The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019; 95:103208. PMC: 7254481. DOI: 10.1016/j.jbi.2019.103208. View

Wilkins J, Gray E, Wallia A, Hirschhorn L, Zembower T, Ho J . Seroprevalence and Correlates of SARS-CoV-2 Antibodies in Health Care Workers in Chicago. Open Forum Infect Dis. 2021; 8(1):ofaa582. PMC: 7787182. DOI: 10.1093/ofid/ofaa582. View